Корпоративные Новости
- Все
- Social Media Feeds
- Корпоративные новости
- События и выставки
28 апреля, 2022
OUR STAFF
15 января, 2022
FarmaMondo and Accendatech USA Inc. partnered to initiate a Managed Access Program for the compassionate supply of ACT-001 for patients in Hong Kong
10 сентября, 2021
Mirum pharmaceuticals and FarmaMondo Group enter into an exclusive commercialization agreement for Russia and CIS region
26 июля, 2021
Ideogen AG and FarmaMondo enter into a managed access program agreement to allow Fotolyn, Beleodaq and Marqibo distribution in Russia, CIS market and Baltics
27 декабря, 2020
Sarepta Therapeutics and FarmaMondo announce an agreement to exclusively manage access of eteplirsen and golodirsen in Russia
10 ноября, 2020
Dompe’ farmaceutici and the FarmaMondo Group: exclusive agreement to distribute oxervate™ in Russia and other CIS countries
1 июня, 2020
FarmaMondo to exclusively manage access to Metreleptin (Myalept®) by Amryt Pharma for patients with lipodystrophy in CIS (excluding Russia)
14 апреля, 2020
EUSA and FarmaMondo Group establishes an Emergency Managed Access Program to allow Healthcare Providers to access Siltuximab (Sylvant©) for off label treatment of acute patients of COVID-19
2 октября, 2019
FarmaMondo to exclusively Manage Access to Lomitapide (Lojuxta®) for the Swiss and CIS markets
1 июня, 2019
FarmaMondo to exclusively manage access of Qarziba® (Dinutuximab Beta) by EUSA Pharma for patients with High Risk Neuroblastoma in LATAM and APAC regions
20 августа, 2018
FarmaMondo to manage access to Asparaginase (Spectrila® by Medac Pharma) for patients with acute lymphoblastic leukemia in Russia and CIS region
15 марта, 2018
FarmaMondo appointed by Amomed Pharma to exclusively Manage Access for Argipressin (Empressin®) for Russia and CIS region
1 января, 2018
FarmaMondo establishes presence in south EU markets to provide direct to hospital service around supply of unlicensed medicines
17 октября, 2017
FarmaMondo to manage access to Dinutuximab beta EUSA for patients with Neuroblastoma
17 октября, 2017
FarmaMondo to manage access to Qarziba® (Dinutuximab Beta) by EUSA Pharma) for patients with High Risk Neuroblastoma in Russia and CIS region
15 августа, 2013